Required section · Section 6 of 6

What the laboratory can support

The spurious case supports an unreliable initial EDTA impedance platelet result due to edge-distributed aggregates and a reliable alternate result only within the local validated procedure. The contrast case supports a true low platelet result because individually resolved platelets are evenly distributed, relevant artifacts are absent, and a suitable method is concordant. Neither case establishes a patient diagnosis, bleeding risk, or universal alternate-tube correction. The method measures particles; clinical interpretation requires reliable laboratory data and appropriate clinical correlation.

Analyzer-specific validation and regulatory implementation belong in the laboratory's implementation record, not in this learner-facing case. That record defines the analyzer and software, reagents, channel hierarchy, interference studies, alternate-anticoagulant process, report comments, and release criteria that make a resolution path reportable.

Revisit HEME-03 for CBC foundations, HEME-06 for smear review, and HEME-07 for platelet morphology prerequisites. Treat thrombocytopenia as a verified laboratory finding only after you have excluded the analytical causes your method can detect.

Knowledge checks

Reading and checks are open. Sign in only to save.

Knowledge check 1

Which statements preserve the stated method and policy boundaries? Select all that apply.

Choose at least 3 options.

Use the laboratory-verified reference interval when localizing the display.

Use optical, fluorescence, manual, or alternate-tube methods only when validated for the local setting.

Avoid assigning a clinical cause from the CBC and smear alone.

Use MPV as proof of platelet production or destruction.

Section status

Finish this section

Reading and checks are open. Sign in only to save.

The module finishes after every required section is marked done and every check in those sections is correct.